Literature DB >> 18027596

[Pharmacodynamics and pharmacokinetics of remifentanil: overview and comparison with other opioids].

Masato Kato1, Daizoh Satoh, Yoshifumi Okada, Kimitoshi Sugiyama, Noriko Toda, Shin Kurosawa.   

Abstract

In this review, the authors tried to summarize the characteristics and main differences of remifentanil with other opioids, and to overview its pharmacodynamics and pharmacokinetics. Clearance and volume of distribution of remifentnail are extremely different from other conventional opioids. In addition, the context-sensitive half time of remifentanil is almost stable (about 3 minutes) even if the continuous infusion of remifentanil lasts for longer than 10 hours. As remifentanil is metabolized by a non-specific esterase, excretion of remifentnil is predictable in basically all patients undergoing general anesthesia and surgery. Therefore, remifentanil is considered to be an optimal opioid as an analgesic combined either with inhalational anesthetics or intravenous hypnotics in balanced general anesthesia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18027596

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  Continuous postoperative infusion of remifentanil inhibits the stress responses to tracheal extubation of patients under general anesthesia.

Authors:  Guoliang Zhao; Xiaoyue Yin; Ya Li; Jianlin Shao
Journal:  J Pain Res       Date:  2017-04-19       Impact factor: 3.133

2.  Remifentanil Preconditioning Attenuates Hepatic Ischemia-Reperfusion Injury in Rats via Neuronal Activation in Dorsal Vagal Complex.

Authors:  Cui Cui; Fang Yu; Suqing Yin; Yuting Yang; Yingfu Jiao; Chiwai Cheung; Xiaomin Wang; Bo Qi; Yaling Liu; Peiying Li; Weifeng Yu; Jie Xiao; Liqun Yang
Journal:  Mediators Inflamm       Date:  2018-05-10       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.